2026 Editorial Calendar
Content themes:
- Bio/Pharma Industry Radar: Top trends impacting the global bio/pharmaceutical industry and its manufacturing value chain.
- CDMO/CMO and Suppliers Report: Key developments from CDMOs/CMOs and suppliers, along with trends shaping outsourcing and pharma ingredients supply.
- Industry Roundtable: : Industry leaders share their perspectives on drug development, commercialization, manufacturing, and supply.
- Manufacturing and Supply Lines: The latest developments impacting the industry’s manufacturing value chain, from raw materials to drug substances (small molecules & biologics) to drug products to packaging.
- Special Reports: Coverage of DCAT webinars and educational programs, including those from DCAT Week and other industry-focused reports.
Editorial Questions or questions about the Editorial Calendar? Contact Patricia Van Arnum, DCAT’s Editorial Director at pvanarnum@dcat.org, Tel: +1-(856)-388-2964
DCAT Value Chain Insights 2026 Editorial Calendar: January-December 2026
| Issue Date |
Content Focus |
| January 9 |
Bio/Pharma Industry Radar: Outlook for 2026 Experts weigh in on the top issues impacting the bio/pharma industry in 2026. |
| January 16 |
The CDMO/CMO & Suppliers Report: The Year Ahead Market outlook for bio/pharmaceutical outsourcing in 2026. |
| January 23 |
Industry Roundtable: Fine Chemicals & Pharma Ingredients Executive insights on the major forces impacting global supply chains for fine chemicals and pharma ingredients. |
| January 30 |
Manufacturing & Supply Lines: Big Pharma Manufacturing Roundup Global update on manufacturing investments of the bio/pharma majors. |
| February 6 |
Bio/Pharma Industry Radar: Blockbuster Potential The leading pipeline contenders expected to launch in 2026 and projected for blockbuster status. |
| February 13 |
The CDMO/CMO & Suppliers Report: Parenteral Drugs Analysis of manufacturing capacity in sterile manufacturing and aseptic fill–finish. |
| February 20 |
Special Report: DCAT Week 2026 Preview A preview of the education programs at DCAT Week 2026 (March 23–26, 2026). |
| February 27 |
Special Report: DCAT Week 2026 Preview A preview of the education programs at DCAT Week 2026 (March 23–26, 2026). |
| March 6 |
Bio/Pharma Industry Radar: ESG & Sustainability Key initiatives in advancing environmental performance, including greenhouse gas reductions. |
| March 13 |
No issue (DCAT Week, March 23–26, 2026). |
| March 20 |
No issue (DCAT Week, March 23–26, 2026). |
| March 27 |
No issue (DCAT Week, March 23–26, 2026). |
| April 3 |
DCAT Week 2026 in Review Key takeaways from the education programs at DCAT Week 2026. |
| April 10 |
Special Report: The Newsmakers: DCAT Week 2026 in Review Roundup from the DCAT Member Company Announcement Forum at DCAT Week 2026. |
| April 17 |
Industry Roundtable: AI, Pharma & Supply Management Executive roundtable on the current & future use of AI in supply management. |
| April 24 |
Manufacturing & Supply Lines: Biomanufacturing Executive insights on manufacturing trends for small-molecule active pharmaceutical ingredients. |
| May 1 |
Bio/Pharma Industry Radar: Orphan Drugs Market overview of the top-selling and blockbuster contenders for rare-disease drugs. |
| May 8 |
The CDMO/CMO & Suppliers Report: TIDES The latest expansions among CDMOs/CMOs in peptides and oligonucleotides and key market trends. |
| May 15 |
Industry Roundtable: Small-Molecule Drugs Executive insights on manufacturing trends for small-molecule active pharmaceutical ingredients. |
| May 22 |
No issue |
| May 29 |
Manufacturing & Supply Lines: Europe Major market, supply chain, and policy moves impacting the pharma industry in Europe. |
| June 5 |
Bio/Pharma Industry Radar: Oncology Drugs Key market trends and leading pipeline contenders and top-selling products in the oncology drug market. |
| June 12 |
The CDMO/CMO & Suppliers Report: Mid-Year Review The key trends impacting the CDMO/CMO sector thus far in 2026. |
| June 19 |
Industry Roundtable: Injectables Executive insights on manufacturing trends for injectable drugs. |
| June 26 |
Manufacturing & Supply Lines: Continuous Manufacturing Near-term and future role of continuous manufacturing in the bio/pharma industry. |
| July 4 |
No issue |
| July 11 |
The CDMO/CMO & Suppliers Report: Mid-Year Review The key trends and developments impacting the CDMO/CMO sector thus far in 2025. |
| July 18 |
From the Executive Suite: The Supply Chain Leaders Ranking and analysis of the top supply-chain organizations. |
| July 24 |
Manufacturing & Supply Lines: Cell & Gene Therapies A roundup of manufacturing investments in cell & gene therapies by CDMOs/CMOs and pharma companies. |
| July 31 |
Special Report: Generics & Biosimilars Market outlook for generic drugs and biosimilars. |
| August 7 |
Bio/Pharma Industry Radar: The Top Deals & Dealmakers Analysis of the top deals in the bio/pharma industry thus far in 2026. |
| August 14 |
The CDMO/CMO & Suppliers Report: Excipients & Drug Products Key market & technology trends in drug products. |
| August 21 |
Industry Roundtable: Packaging Senior executives on the key trends shaping the market for primary packaging. |
| August 28 |
No issue |
| September 4 |
Bio/Pharma Industry Radar: Emerging Pharma Leaders Analysts weigh in on the leading Emerging Pharma companies on the industry’s radar. |
| September 11 |
The CDMO/CMO & Suppliers Report: Antibody Drug Conjugates & Other Complex Conjugates Market trends & the latest developments in ADCs & other complex conjugates. |
| September 18 |
Industry Roundtable: The Innovation Leaders Executive roundtable on what is driving innovation across the bio/pharmaceutical industry. |
| September 25 |
Manufacturing & Supply Lines: Supplier Relationship Management Senior executives share perspectives on optimizing the pharma customer–supplier relationship. |
| October 2 |
Bio/Pharma Industry Radar: Small-Molecule APIs Analysis of the top-selling small-molecule drugs and pipeline contenders. |
| October 9 |
The CDMO/CMO & Suppliers Report: Biomanufacturing The latest expansions and trends in contract biomanufacturing. |
| October 16 |
Industry Roundtable: Drug Products Executive insights on technology and manufacturing trends for solid dosage and injectable drugs. |
| October 23 |
Manufacturing & Supply Lines: Digitalization, Data Integrity & Cybersecurity Senior executives share perspectives on the use of digitalization in managing global supply chains. |
| October 30 |
Special Report: India Major market, supply chain, and policy moves impacting the pharma industry in India. |
| November 6 |
Bio/Pharma Industry Radar: The Pipeline Contenders Analysts weigh in on leading late-stage drug candidates with strong market potential. |
| November 13 |
The CDMO/CMO & Suppliers Report: Biomanufacturing The latest expansions and trends in contract biomanufacturing. |
| November 20 |
Industry Roundtable: Innovation: New Modalities Executives weigh in on the top product innovations from 2026. |
| November 27 |
No issue |
| December 4 |
Bio/Pharma Industry Radar: The Year in Review A look at the top 10 developments in the bio/pharma industry in 2026. |
| December 11 |
TThe CDMO/CMO & Suppliers Report: The Movers & Shakers of 2026 A look at the top moves from CDMOs/CMOs in 2026. |
| December 18 |
No issue. |
| December 25 |
No issue. |
